Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 01-2017 | 10-2016 | 07-2016 | 04-2016 | 01-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,978 | 3,922 | 3,849 | 2,182 | 803 |
| Marketable Securities | 152 | 528 | 930 | N/A | 1,805 |
| Receivables | 198 | 175 | 149 | 103 | 89 |
| TOTAL | $4,362 | $4,676 | $4,972 | $2,303 | $2,712 |
| Non-Current Assets | |||||
| PPE Net | 91 | 20 | 22 | 23 | 24 |
| TOTAL | $91 | $20 | $22 | $23 | $24 |
| Total Assets | $4,453 | $4,696 | $4,994 | $2,325 | $2,736 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 137 | 144 | 270 | 192 | 267 |
| TOTAL | $562 | $638 | $848 | $791 | $863 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 425 | 494 | 579 | 599 | 596 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $562 | $638 | $848 | $791 | $863 |
| Shareholders' Equity | |||||
| Common Shares | 24,674 | 24,818 | 25,389 | 21,759 | 21,063 |
| Retained earnings | -24,349 | -24,253 | -24,694 | -23,369 | -22,116 |
| Other shareholders' equity | 745 | 749 | 767 | 705 | 682 |
| TOTAL | $3,892 | $4,057 | $4,145 | $1,534 | $1,873 |
| Total Liabilities And Equity | $4,453 | $4,696 | $4,994 | $2,325 | $2,736 |